Background: Complex Regional Pain Syndrome (CRPS) symptoms can significantly differ between patients, fluctuate over time, disappear or persist. This leads to problems in defining recovery and in evaluating the efficacy of therapeutic interventions. Objectives: To define recovery from the patients' perspective and better understand their priorities for treatment approaches. Methods: Establishing an international consortium, we used a 2-Round Delphi-based study in eight countries across Europe and North America. Participants ≥18 years who met, or had met, Budapest clinical criteria were included. Round 1 participants completed the statement: 'I would/ do consider myself recovered from CRPS if/because. . .' alongside demographic and health questionnaires. Data were thematically organised and represented as 62 statements, from which participants identified and ranked their recovery priorities in Round 2. Results: Round 1 (N = 347, 80% female, 91% non-recovered) dominant ICF themes were: activities of daily living; bodily functions; external factors; participation and personal factors. The top five priority statements in Round 2 (N = 252) were: no longer having (1) CRPSrelated pain, (2) generalised pain and discomfort, (3) restricted range of movement, (4) need for medication, (5) stiffness in the affected limb. With very few exceptions, priorities were consistent, irrespective of patient demographics/geography. Symptoms affecting daily activities were among those most frequently reported. Conclusions: Our data showed a small number of themes are of highest importance to CRPS patients' definition of recovery. Patients want their pain, movement restriction and reliance on medication to be addressed, above all other factors. These factors should therefore be foremost concerns for future treatment and rehabilitation programmes. Significance:
Introduction
Complex Regional Pain Syndrome (CRPS) is a pain condition diagnosed using validated clinical diagnostic criteria known as the Budapest criteria (Harden et al., 2010) . Signs and symptoms are usually limited to a single limb, which may include oedema, altered hair and nail growth, sensory, motor and autonomic disturbances (Harden et al., 2010) . In addition, disrupted body perception and dis-ownership of the affected limb are commonly described (Galer et al., 1995; Galer and Jensen, 1999; Moseley, 2005; Frettl€ oh et al., 2006; Lewis et al., 2007) . Symptoms usually develop following trauma to a limb but very rarely can occur spontaneously (Stanton-Hicks et al., 1995; Birklein and Schlereth, 2015) .
For the majority, CRPS resolves within a year, but prospective studies have indicated severe pain remains for 13% of patients ≥1 year after diagnosis (Zyluk, 1998) and stiffness continues to affect up to 65% (Bickerstaff and Kanis, 1994) . Evidence synthesis of longer term retrospective studies report the persistence of symptoms for between 22% and 64% of patients ≥3 years after diagnosis (Bean et al., 2014a) . Unremitting symptoms in CRPS are associated with long-term disability, poor psychological health and reduced quality of life (QoL; Field et al., Patients' experience of chronic pain is moderated by multiple psychosocial, behavioural and physiological factors (Hush et al., 2009; Dansie and Turk, 2013) , and 'recovery' is an individual construct, dependent on idiosyncratic appraisal of the impact of symptoms on daily activities (Hush et al., 2009) . People adjust to accommodate their changed health status, leading to 'response-shift': a recalibration, re-evaluation or reprioritisation of health standards (Sprangers and Schwartz, 1999) . This can confound traditional preand post-intervention assessments (Osborne et al., 2006) . Furthermore, where there may be limited physical signs of an obvious cause of persistent pain and disability, such as long-term CRPS, 'recovery' is a far from simple construct (Beaton et al., 2001) .
Recommendations from the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) promote patient-centred research, and advocate allowing patients to describe what is important to them when defining recovery (Dworkin et al., 2008) .
To achieve a comprehensive understanding of patient-defined recovery, and the factors that influence this, an international consortium was established in 2012 comprising patients, clinicians and academics from eight countries across Europe and North America. Consortium members either had research or clinical expertise in CRPS, relevant methodological expertise, or could represent the patients' perspective for this condition. We present here findings from a 2-Round Delphi-based study aiming to define recovery from CRPS from the patients' perspective. centres obtained local institutional and health services approvals. All approvals were seen by the lead centre (UK) prior to data collection commencing. In addition, participants recruited from pre-existing site specific, or country specific, registries and databases had given prior consent to be contacted for future research purposes. Participants' consent was otherwise assumed by the return of completed questionnaires.
Development of study protocol
Five workshops were convened between July 2012 and January 2015 (see Supporting Information  Fig. S1 ). All workshops were conducted following a structured format with clear aims, objectives and specified methodological formats. All decisions were subject to majority consensus between workshop attendees. Further details of each workshop are given below. Fig. S2 ). This framework had previously been used successfully by RP and FB (Brunner et al., 2008 Boogaard et al., 2011) .
Workshops
2.2.1.3 Workshop 3. Within this workshop, recruitment activity and data collection to date were discussed and consensus reached how the coding framework would be applied for the on-going qualitative data analysis. Consortium members assessed and confirmed the standardisation of the initial coding using early Round 1 qualitative data.
2.2.1.4 Workshop 4. This was held to review the emergent themes from the qualitative analysis of the Round 1 data and to agree the wording and analysis strategy for Round 2 data. Consortium members reached consensus about which statements comprehensively represented patients' perceptions of recovery and the content of the Round 2 questionnaires.
2.2.1.5 Workshop 5. Full qualitative results from Round 1 were presented, and findings from preliminary analyses of the quantitative data were reviewed. A strategy was agreed for further data analysis and dissemination of all study findings.
Study participants
Potential participants ≥18 years who had met the Budapest CRPS diagnostic criteria (Type 1 or Type 2, confirmed by clinical records) (Harden et al., 2010) were identified from eight country-specific CRPS databases or clinic-specific research lists: UK (Bath), Germany (Mainz; Erlangen, F€ urth), USA (Chicago), Canada (Toronto; Longueuil, Quebec), Switzerland (Zurich), Denmark (Aarhus), the Netherlands (Trauma RElated Neuronal Dysfunction Consortium) and Poland (Pomerania). Participants were included if they were able to understand the written documents, as subsequently indicated by return of a completed questionnaire. (Documents were provided from each study centre in the language concordant with what was spoken in that country. See Section 2.4.3) Exclusion criteria were a diagnosis of CRPS following any cerebrovascular problems or cardiac event.
To achieve a more or less equal distribution of relevant patient characteristics across countries, and taking into account that we wanted to be able to form strata based on gender, age (three groups), disease duration (three groups) and employment status (yes/no), we aimed to recruit 36 patients per country. With nine countries (we counted Canada as 2, because the two institutes are in different language areas), this totalled 324 patients. Considering a nonresponse rate of 50%, we calculated we would have to send out at least twice this number of questionnaires. We ultimately sent out questionnaires to 679 potential participants.
Each centre was responsible for local recruitment, with purposive sampling used to capture a range of disease durations and employment statuses (Mays and Pope, 2000) . Potential participants were sent a letter of invitation by post, except for newly diagnosed patients (≤1 year CRPS duration) not yet recruited to a CRPS database. In these cases, eligibility was determined by a member of each site's clinical team, and a letter of invitation was provided to participants when attending that site's outpatient clinic. Individual centres were responsible for all data collection from participants they recruited.
Only those participants who completed Round 1 documentation were potential study participants for Round 2 of the study.
Procedure

Round 1
The invitation mailing included: a Round 1 questionnaire pack (Part A and a sealed envelope containing Part B); an envelope for the completed Part A questionnaires; and a pre-paid envelope for the return of all completed documents. Part A questions asked for demographic information (date of birth, gender, employment status, years of formal education, limb affected, hand dominance); participants' perception of what stage they were in the disease (early, late, recovering, recovered); whether they had CRPS type 1 or 2 (with no, or known, major nerve damage respectively); the date the patient believed the CRPS symptoms started; and whether they cared for other family members inside/outside of the home. Participants were asked to indicate if they considered themselves (1) not recovered from CRPS, (2) partially recovered from CRPS or (3) fully recovered from CRPS. Instructions against responses to (1) or (2) asked participants to answer the open question in fewer than 100 words: 'I would consider myself recovered from CRPS if . . ..'. Where participants indicated (3) (they had recovered from CRPS), instructions asked them to answer: 'I do consider myself recovered from CRPS because . . .'.
Part B questions asked: the date the participant's CRPS commenced; whether the CRPS symptoms were related to trauma or were spontaneous; and what other health conditions affected the participant's life. To give an indication of disease status, participants were asked to indicate which symptoms (from a list of fifteen derived from the Budapest CRPS criteria) they had experienced in the prior 48 hours. They were also asked to complete a number of standardised health outcome questionnaires, further details of which are given below in Section 2.4.3.
Written instructions made it clear to participants that they should complete the Part A questionnaires and seal their responses in the envelope provided before opening the envelope containing Part B and completing the questionnaires contained inside. This was to ensure that responses to the open-ended question were not prejudiced by completion of the standardised health questionnaires. However, as questionnaires were completed in patients' homes, we had to rely on their voluntary adherence to this protocol. Participants were asked to return all questionnaires to their local study centre in a provided prepaid envelope within 2 weeks of the date of their letter of invitation.
Study questionnaires had been pre-tested with a small number of patients in the UK and the USA for usability and modified as required prior to ethical approvals being obtained. All questionnaire packs, irrespective of language or study centre, were printed and compiled in the lead (UK) centre for consistency, prior to posting to each recruitment site.
Round 2
Derived from responses to the open question in Round 1 (as described above), participants who had submitted completed questionnaires were presented with 62 statements relating to perceptions of recovery (see Section 3). These statements had been listed in random order and translated as necessary. Added to this was a further statement (number 63): 'I do not find any of these statements important with regards to my recovery from CRPS'. Participants were asked to complete the statement: 'My idea of recovery from CRPS is. . ..' by selecting, from the statements, the 10 they felt were most relevant to their idea of recovery from CRPS. A minimum of 3 statements was specified for those who felt unable to select 10. Participants were then asked to rank their selected statements in order of relevance (where 1 = most relevant, 2 = second most relevant and so forth). The standardised health outcome questionnaires (see Section 2.4.3) used in Round 1 were also repeated in Round 2.
Standardised health outcome questionnaires
The Radboud Skills Questionnaire (RASQ; Oerlemans et al., 2000) (for those with upper limb CRPS only) is a self-report questionnaire of upper limb physical function in CRPS. It contains items representing the 'disabilities due to hand disease' domain, of the Dutch elaboration of the International Code of Impairments, Disabilities and Handicaps. The RASQ questionnaire comprises 45 items across 11 categories, including personal care, domestic and other activities.
The Measuring Activity Limitations in Walking Questionnaire (v.5) (Roorda et al., 2004 ) (for those with lower limb CRPS only) is a self-administered questionnaire, appropriate for all age groups living at home with lower-extremity disorders. Items ask patients about what they can actually do, rather than what they think they can do, in terms of walking. Not all of the 41 items are required (Roorda et al., 2005) and 35 items relating to walking at home and walking outside were selected for use in the present study, with permission from the developer.
The Short Form McGill Pain Questionnaire (Melzack, 1987 ) is a self-report questionnaire providing a comprehensive assessment of subjects' pain. It includes a 0-10 visual analogue rating scale of pain intensity and a list of 15 pain descriptors to capture pain quality.
The Short Form Health Survey (SF-36) Questionnaire (Ware et al., 1993 ) is a self-report measure of subjective health status comprising 36 items across eight dimensions: physical function, social function, role limitations due to emotional problems, role limitations due to physical problems, mental health, energy/vitality, pain and general health perception.
The EQ-5D-3L (The EuroQoL Group 1990) descriptive system contains five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has three levels: no problems, some problems, and extreme problems. It is applicable to a wide range of health conditions and treatments, and can provide an index value for health status.
The Acceptance and Action Questionnaire II (AAQ-II) (Bond et al., 2011 ) is a self-report measure of 10 items and was used in the present study to assess patients' ability to accept unwanted emotional experiences or thoughts arising from their experience of pain. It is suitable for use with chronic pain patients, and prior findings suggest greater acceptance leads these patients to function better and to suffer less (McCracken and Zhao-O'Brien, 2010) .
Where translations of study documentation from English were required (e.g. the patient information sheet, some outcome measures) these were provided by individual study centres for their respective country: Danish (Demark); French (Canada -Quebec); German (Germany -Mainz and Erlangen, Switzerland); Polish (Poland) and Dutch (the Netherlands).
This process was followed in reverse to translate qualitative study data into English. The translation process followed an iterative forward and backward approach with two translators, who were both fluent in the relevant two languages (one was the local study investigator and the other was independent from the study) to ensure consistency of meaning across countries. This followed a tried and tested validated process as previously used successfully by study collaborators (FB, RP, JM) . Validation of new language versions of the outcome measures was conducted concurrently with this study.
Data analysis
Quantitative and qualitative data were anonymised in each participating site, translated into English where required (as described above), and entered into a bespoke Microsoft Excel study template. These anonymised data were then sent electronically to the lead (UK) centre. Whilst we had asked participants to state whether they were non-recovered, partially recovered or fully recovered (as study consortium members felt only offering dichotomous recovered/non-recovered response options might be uncomfortable for some patients), for the purposes of study data analyses, partially-recovered and non-recovered data were combined under the category 'non-recovered'. Similarly, as the treatment for CRPS 1 and 2 is the same according to IASP criteria and the challenges around definitions of recovery are the same, we did not differentiate between type 1 and type 2 in our analysis.
Quantitative data
Data were analysed to identify frequency of recovery/ non-recovery, gender, age, duration and location of CRPS and whether CRPS onset was spontaneous or followed trauma (e.g. fracture). The frequency of individual symptom reporting by recovery/nonrecovery was also identified. Chi-squared tests of association were used to detect associations between the number of reported symptoms and self-reported recovery, and between recovery and demographic characteristics. Data from the non-recovered subsample were further examined with Odds Ratio analyses and Welch's t-tests to determine associations between symptoms and the limb that was affected (upper or lower -data from patients with CRPS in both upper and lower limbs were excluded from these analyses). The study was explorative in nature, hence no hypotheses of differences, or comparisons of data, between each country were made.
To analyse the Round 2 data, statements selected and ranked by participants were weighted for importance (priority 1 = 100%, 10 = 10%) and cumulative weighted percentages calculated for those statements quoted by ≥5% of respondents, in order to identify the top five statements overall. Sub-group analyses identified the top three statements by geographical region, gender, recovery status (recovered/ non-recovered), age, employment, duration and site of CRPS.
Qualitative data
Training in thematic analysis was provided by FB and RP for a core analysis team of Expert Patient and academic researchers (IT, CS, YH, FB & RP). On receipt of completed questionnaires, Round 1 data were entered on to a common electronic template and transferred electronically to a single site (at the RNHRD, Bath UK). YH conducted an initial analysis of early responses using deductive analysis with QSR NVivo in order to identify the emerging themes (Braun and Clarke, 2006) . These themes were then categorised according to the World Health Organisation's (WHO) ICF (World Health Organization 2001) framework. The core analysis team and other members of the Consortium (selected based on their previous experience/knowledge of content analysis and to ensure representation across the participating countries), also jointly analysed a sample of data to ensure consistency of coding and subsequent categorisation according to this framework.
YH subsequently completed the data coding, analysing the data from non-recovered participants separately from that received from recovered participants, and consulting with the core analysis team for guidance where required. The core analysis team members reached consensus about any phrases not immediately fitting the classification system and where several different terms were judged by the researchers to describe the same issue, these were grouped together to form a universal description (Hasson et al., 2000) . Editing of the original phrases and words was otherwise kept to an absolute minimum. Descriptions and grouping systems were also verified by two other members of the research team and by two other Expert Patient Researchers to confirm inter-rater reliability.
The frequency of themes within the data was noted for both the recovered and non-recovered subgroups and the top 50% of themes extracted. Led by JM, the Consortium members considered the statements for each of these themes that were felt to best represent patients' perceptions of recovery. The final agreed items were listed in a random order to form the questionnaire for Round 2.
Results
Qualitative data
Round 1 questionnaires were sent to 679 patients and were returned by 347 (51%, 80% female, 91% non-recovered, 53% disease duration ≥3 years, mean age 53 years (range 18-85)) (See Table 1 ).
Dominant themes from the open text responses to the qualitative question about patient-defined recovery were as presented in Table 2 . When these themes were categorised under the main WHO ICF framework, the majority of data fell into four key headings: activities of daily living; bodily functions and structures (including symptoms and pain); Some participants had CRPS in more than one limb, hence summating these figures will give a total which exceeds the overall sample size (N = 347/100%).
external factors (including medication use) and participation (e.g. housework, shopping). Personal factors (anxiety, depression) were least represented. Please see Supporting Information Table S1 for illustrative quotes from the most frequent themes, showing how these were categorised within the ICF framework, and indicating the country of origin of each quoted participant. From the analysis of the Round 1 data, 62 statements were identified to represent the dominant themes of patient-defined recovery (See Table 3 ). These formed the basis of the Round 2 questionnaire, which was sent to the same 347 patients who had responded in Round 1.
Quantitative data
Of the 347 Round 1 participants, 310 reported their recovery status and completed symptom and standardised health outcome questionnaires: 280 (90.3%) 'non-recovered'; 80% female; average age 52 years (range 19-85 years); 51% disease duration ≥3 years. Responses to other demographic questions showed: 70/ 40% upper/lower limb affected (some having CRPS in both an upper and lower limb); 55/53% right/left side affected (some having bilateral CRPS); 91/9% traumaprecipitated/spontaneous onset of CRPS. Responses to the standardised health outcome questionnaires are presented in Supporting Information Fig. S3 . Both 'non-recovered' and 'recovered' participants reported symptoms in the prior 48 hours (see Table 4 ). The three most frequently reported symptoms for 'non-recovered participants' were: muscle weakness (90%); a decreased range of motion in the affected limb (87%); and temperature differences from side to side (78%). This was also true for participants who classified themselves as 'recovered': 31% reported muscle weakness; 33% a decreased range of motion; and 27% temperature differences.
Self-reported recovery and number of symptoms were strongly associated (v 2 = 124.94, df = 15, p < 0.001). For those reporting <5 symptoms, 34% reported themselves as recovered, compared to 2% of those with five or more symptoms. There were no associations between self-reported recovery status and gender, disease duration, whether onset was post trauma or spontaneous, or limb affected.
Non-recovered participants with lower-limb CRPS more frequently reported allodynia (OR 1.93, CI = 1.12-3.33, p = 0.021), hyperalgesia (OR 2.60, CI = 1.40-4.83, p = 0.003), changes in hair growth (OR 1.86, CI = 1.08-3.21, p = 0.035), and involuntary muscle movements (OR 1.78, CI = 1.05-3.04, p = 0.042) than those with upper-limb CRPS. They also had poorer MPQ (p < 0.01), EQ-5D (p < 0.05), SF-36 Physical Functioning (p < 0.001) and Energy/ Fatigue (p < 0.05) scores (see Table 5 ).
Round 2 responses, whereby patients ranked the relevance of the 62 statements, were received from 252 patients (73%, 77% female, 90% non-recovered) (see Table 6 ). The statements ranked as the top five priorities across the whole sample were: no longer having (1) CRPS-related pain, (2) generalised pain and discomfort, (3) restricted range of movement, (4) need for medication, and (5) stiffness in the affected limb/s. These themes were mirrored in the top three statements for each geographical region, apart from: having improved sleep and rest (UK, Denmark), and no longer having involuntary movement in the affected limb/s (The Netherlands).
The top three statements of most subgroups (males, females, recovered, non-recovered, age groups 30-50 and 50+, paid employment, nonemployed, all disease durations, upper and lower limb CRPS) were all within the overall top five priority list. Individual exceptions were: having a better QoL (participants aged 18-30) and improved sleep and rest (non-paid workers).
Discussion
While it is known that CRPS can resolve spontaneously, studies suggest that for some patients, symptoms can persist and lead to long term-disability (De Mos et al., 2009; Beerthuizen et al., 2012; Bean et al., 2016) . The primary aim of this international study was to define recovery from the patients' perspective, and to understand the factors that may influence this.
When each participant was asked to describe what would lead them to consider themselves recovered from CRPS, responses showed that patient-reported impacts of CRPS fall across the breadth of the WHO ICF categories. The largest number of reports related to: activities of daily living; bodily functions and structures (including symptoms and pain); external factors (including medication use), and participation (e.g. housework, shopping). These findings support prior studies suggesting CRPS interferes with many aspects of life including self-care, work and mobility (Kemler and de Vet, 2000; Sharma et al., 2009) .
Interestingly, psychological factors, such as anxiety and depression, which fall within the ICF 'personal factors' category, were least represented amongst the Changes to the growth of hair on affected part 37. themes patients reported as important for recovery. The literature on the role of psychological factors in CRPS is contradictory. While some studies suggest psychological factors have little bearing on the development and longevity of CRPS (Puchalski and Zyluk, 2005; Beerthuizen et al., 2009 Beerthuizen et al., , 2011 , others have found associations between CRPS outcomes and anxiety (Dilek et al., 2012; Bean et al., 2014b; Bean et al., 2015) . In our study, patient research partners within the research team, suggested affect is a consequence of CRPS symptoms, not a symptom per se. Previous research has similarly concluded altered psychological functioning is a natural outcome of chronic pain, rather than a specific psychological profile characteristic of CRPS patients (Lohnberg and Altmaier, 2013) . Furthermore, the phrasing of our open question may have elicited patients' primary complaints, such as pain and function, rather than secondary consequences of these symptoms, such as psychological distress. Through selection and ranking of the most important factors that would enable participants to personally consider themselves recovered, participants reported they want, in priority order: to be relieved of CRPS pain, and generalised pain and discomfort; to have improved movement; and to have a reduction in medication, and stiffness in their limbs.
Given the intensity of CRPS pain, we were not surprised that this was patients' highest priority. However, the frequency with which the factor: 'generalised pain and discomfort' was identified by all sub-groups, was unanticipated. Widespread muscle hyperalgesia affecting non-CRPS affected limbs and the cheek area, has previously been reported in CRPS patients with longstanding disease (van Rooijen et al., 2013) . It is considered most likely this unspecific pain relates to central sensitization, a process in which innocuous stimuli become, and remain painful in chronic pain conditions, such as CRPS (Goebel, 2011) . Our findings underline the importance of using measures to capture non-specific, as well as distinct, CRPS pain in research and clinical practice, and to consider both aspects when determining therapeutic interventions.
A recent qualitative study, exploring what patients consider important to recovery following hip fracture, found mobility, and its relevance to personal care and valued day-to-day activities, was the most important factor (Griffiths et al., 2015) . Our data similarly suggest that while reduction of pain remains a fundamental treatment aim, the patients' desire for restoration of function supports multidisciplinary treatment approaches focussing on the goals and needs of daily living.
We are not aware of previous studies that have specifically identified the importance of reducing reliance on medication, when defining recovery in musculoskeletal conditions. Whilst medication may be one cornerstone for the treatment of chronic pain, our data suggests that people with CRPS may value exploring non-pharmacological coping and treatment strategies in order to meet their goal of reducing medication. Cognitive behavioural approaches, such as Acceptance and Commitment Therapy (Hayes et al., 2006) , may be helpful in this regard.
There is a paucity of research into individual differences in the impacts of CRPS. However, our data suggest that treatment targets vary little between patients; indicating group based therapeutic interventions maybe as effective as more individually tailored treatment approaches. We were particularly interested in the consistency of factors identified by participants as most important in defining recovery across the subgroups. Results showed that these factors were mostly irrespective of gender, recovery status, age, employment status, disease duration and site of CRPS (upper or lower limb). The minor country-specific differences we saw could be attributable to referral variation. For example, CRPS clinicians in The Netherlands have particular expertise in CRPSrelated movement disorders and this may explain why resolution of involuntary movements was a particular priority for the Netherlands cohort.
Muscle weakness and decreased range of motion were the most frequent symptoms reported by participants in our quantitative data. These findings correspond to the importance of improved motor function and reduced stiffness, as identified as recovery priorities in our qualitative data, and underline the importance of addressing factors affecting physical function in CRPS treatment pathways. While temperature differences between the affected and unaffected limb were also frequently reported symptoms, our findings suggest autonomic features are considered by patients to be less important in their definition of recovery than aspects of their condition that deleteriously impact daily activities.
Interestingly pain was not among the most frequently reported symptoms, despite it being identified as of highest importance to recovery. It is possible that these, seemingly contradictory findings may be the product of response shift (Schwartz et al., 2007) , and the nature of the dichotomous questions asked. In our study, patients were asked whether or not, in the last 48 h, they had experienced 'pain going on longer than expected/greater than expected' and whether stimuli that 'normally do not cause pain', or 'normally cause only slight pain' had been painful/more painful. It is plausible that participants' acceptance of their everyday pain meant they only reported pain beyond that which was typical for them, and which they already considered as 'normal'.
Given the nature of CRPS, and the breadth of symptoms in diagnostic criteria, it is unsurprising our data showed, that the likelihood of a participant considering him/herself to be recovered was closely related to the number of symptoms reported. However, even those who classified themselves as 'recovered', had still experienced symptoms in the prior 48 hours. In a similar way, post myocardial infarction, patients have also reported recovery as an ongoing and unstable process of learning to live with feeling 'different' from before (Tod, 2008) . This presents an interesting insight into how people conceptualise recovery and suggests that it is more complex than the simple absence or presence of symptoms. Within this context, it poses the question: what constitutes appropriate treatment to address the residual functional needs people with CRPS? For example, should people who no longer meet the diagnostic criteria, but who nevertheless have ongoing disabling symptoms, still be offered the full breadth of 'usual' CRPS care, or should they receive more specific approaches, individually tailored to their remaining functional impairments? Future studies are needed to determine the most functionally beneficial and cost effective solutions across the disease trajectory.
Sub-group analysis of our quantitative data from non-recovered patients, indicated poorer outcomes for those with lower limb CRPS, than those with CRPS of the upper limb. This was true for our standardized measures of pain, physical functioning, QoL and energy/fatigue. These findings fit well with previous work citing lower self-reported QoL in the physical domain of the SF-36, for those with lower limb CRPS (van Velzen et al., 2014) .
A contributing factor to these poorer outcomes in lower limb CRPS may be our finding that these participants had a higher mean pain score on the MPQ, and more frequently reported allodynia and hyperalgesia, than those with upper limb CRPS. Furthermore, they more frequently reported changes in hair growth and involuntary muscle movement. Involuntary movements have been previously reported to occur significantly more often in CRPS affected legs than arms (Frettl€ oh et al., 2006) . Beyond the respective prevalence of upper and lower limb CRPS, we are not aware of any other studies that have compared and contrasted the incidence and specificity of symptoms according to localization. More research is needed to understand the differential implications of CRPS site, on patient outcomes.
A limitation of our study was the small 'recovered' sample (9%). This sample was probably a consequence of our pragmatic recruitment strategy, approaching participants from CRPS databases and research lists. The greater duration of CRPS, the more likely a patient would be enrolled into a condition-specific database. Furthermore, those who are fully recovered may be less inclined to complete a CRPS-focused questionnaire, as it lacks relevance to them any more. A lack of statistical power in the available sample size therefore precluded analysis of between group differences.
We are mindful that our study was reliant on selfreport of symptoms, which were not clinically verified and that this may be considered a study limitation. Furthermore, much of the outcome measure data was unique to the study protocol and therefore only available for those who completed and returned the questionnaires. For this reason, and because clinical records differ greatly between countries, we were unable to investigate any potentially significant differences between those who did, and did not return questionnaires. Future studies with greater equipoise between recovered/non-recovered cohorts, the inclusion of a clinical assessment, and consideration of study participant/non-participant data would be informative.
Our data adds a unique perspective to current understanding of recovery, as defined by patients. Our findings suggest a very small number of themes are of highest importance to people with CRPS in their definition of recovery, and these vary little with demographics. Irrespective of where a person with CRPS is in the disease trajectory, and whether or not they still meet diagnostic criteria, they want their CRPS-related pain, generalised pain, movement difficulties, and medication reliance to be addressed, above all other factors, for them to consider themselves recovered. These factors should therefore be considered as foremost in the development and design of future treatments and multidisciplinary rehabilitation programmes. study of our friend and co-author Professor Roberto Perez, who sadly passed away prior to publication.
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